News | January 14, 2025

Avance Clinical Leads As The CRO Of Choice For Early Phase Clinical Trials In Australia – Announced At Biotech Showcase 2025

This success is a direct result of its three decades of experience and proven track-record in delivering high-quality, cost-effective, and efficient clinical trial services for biotech companies worldwide.

Australia’s clinical trial environment, coupled with Avance Clinical’s deep scientific and regulatory expertise, enables biotechs to significantly reduce both the time and cost of getting therapies to market.

Avance Clinical’s operations in Australia is renowned for its fast Phase I startup times with approvals of around five weeks – one of the quickest timelines globally.

Additionally, biotechs conducting trials in Australia with Avance Clinical benefit from the country’s lucrative rebate of more than 40% on eligible clinical trial spend, making it one of the most attractive financial incentives worldwide. Australia does not require an open IND which means even faster study activations offering significant cost and time benefits.

Known for providing high-quality data and world-class in-house regulatory affairs planning, Avance Clinical is also highly regarded for its ability to navigate complex clinical development challenges while maintaining flexible, solution-oriented approaches.

“Our clients often tell us they choose Avance Clinical because of our hands-on, agile approach and the seamless integration we provide between early-phase trials in Australia and later-phase trials in the US and Asia”; said Liahna Toy, Vice President of Commercial Business Development at Avance Clinical. “This allows our clients to focus on their science, while we handle the complex logistics, ensuring they meet key milestones without unnecessary delays.”

Avance Clinical CEO Yvonne Lungershausen said Avance Clinical’s North American and Asia offices (Taiwan and South Korea) offer expansive patient access for later stage multi- regional studies.

“This global reach ensures Avance Clinical is well-positioned to support biotechs as they move from early-phase to later-phase trials, leveraging speed, efficiency, and a deep understanding of diverse patient populations,” she said.

Meet the Avance Clinical leadership team in San Francisco, at Biotech Showcase 13-15 January 2025.

Source: Avance Clinical